Tag: Multiple
Cambium Networks Expands Collaboration with Facebook Connectivity for Multiple Wireless Access Initiatives

Cambium Networks Expands Collaboration with Facebook Connectivity for Multiple Wireless Access Initiatives

Facebook Connectivity's Terragraph solution enables Cambium Networks to provide last mile access to subscriber homes, enterprises and multi-dwelling buildings ROLLING MEADOWS, ...

Lees verder
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus

WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus

SHANGHAI, Jan. 29, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions ...

Lees verder
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

-- The 12(th) global licensing partnership for WuXiBody(TM) since its launch in August 2018 showcasing the power and versatile applications of ...

Lees verder
Fiasp® Demonstrated Effective Overall Blood Sugar Reductions in People With Advanced Type 2 Diabetes Uncontrolled on Multiple Daily Injections (B

Fiasp® Demonstrated Effective Overall Blood Sugar Reductions in People With Advanced Type 2 Diabetes Uncontrolled on Multiple Daily Injections (B

BAGSVÆRD, Denmark, Sept. 17, 2019 /PRNewswire/ -- New data presented today at the 55(th) Annual Meeting of the European Association for the Study of Diabetes (EASD) showed ...

Lees verder
Merck Data at ASCO 2019 Showcase Multiple Innovative Molecules with Potential to Impact Unmet Needs in Cancer Care

Merck Data at ASCO 2019 Showcase Multiple Innovative Molecules with Potential to Impact Unmet Needs in Cancer Care

DARMSTADT, Germany, May 15, 2019 /PRNewswire/ -- Not intended for UK- , Canada- or US-based media ASCO Abstract # Bintrafusp alfa (bifunctional fusion protein): TPS9114; ...

Lees verder
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada

Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada

DARMSTADT, Germany, December 4, 2017 /PRNewswire/ -- - First oral short-course treatment for relapsing- remitting multiple sclerosis (RRMS) now approved in ...

Lees verder
New Data at ECTRIMS Highlight Positive Benefit-Risk Profile of Mavenclad in Relapsing Multiple Sclerosis

New Data at ECTRIMS Highlight Positive Benefit-Risk Profile of Mavenclad in Relapsing Multiple Sclerosis

DARMSTADT, Germany, October 26, 2017 /PRNewswire/ -- - Data suggests Mavenclad may significantly increase proportion of patients exhibiting no evidence of ...

Lees verder
Cladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis

Cladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis

DARMSTADT, Germany, June 23, 2017 /PRNewswire/ -- - Efficacy and safety data support positive benefit/risk assessment from CHMP  - Cladribine Tablets is the ...

Lees verder
BizPress.nl